Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Reduction of Impulsivity in Patients With Borderline Personality Disorder Using Dual-site Transcranial Magnetic Stimulation

NCT05942651 is registered in ClinicalTrials.gov with Hôpital le Vinatier as lead sponsor.

NCT NCT05942651
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05942651 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Reduction of Impulsivity in Patients With Borderline Personality Disorder Using Dual-site Transcranial Magnetic Stimulation
Lead sponsor
Hôpital le Vinatier
Phase
Not applicable
Overall status
Recruiting
Start date
January 8, 2024
Completion date
September 20, 2027
Enrollment
40 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

borderline personality disorder